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The diagnosis of acute pelvic inﬂammatory disease (PID) is usually based on clinical criteria and can be challenging for even the
most astute clinicians. Although diagnostic accuracy is advocated, antibiotic treatment should be instituted if there is a diagnosis
of cervicitis or suspicion of acute PID. Currently, no single test or combination of diagnostic indicators have been found to reliably
predict PID, and laparoscopy cannot be recommended as a ﬁrst line tool for PID diagnosis. For this reason, the clinician is left with
maintaining a high index of suspicion for the diagnosis as he/she evaluates the lower genital tract for inﬂammation and the pelvic
organs for tenderness in women with genital tract symptoms and a risk for sexually transmitted infection. This approach should
minimize treating women without PID with antibiotics and optimize the diagnosis in a practical and cost-eﬀective way.
1.Introduction
Acute PID is associated with signiﬁcant sequelae including
tubal factor infertility, ectopic pregnancy, and chronic pelvic
pain. To ameliorate these adverse outcomes, an approach
to its diagnosis must promote the ability to intervene with
antimicrobial therapy early on the course of this ascending
infection. It is less important to accurately determine where
the patient may lie along the continuum of this ascending
inﬂammatoryprocess(cervicitis,endometritis,salpingitis,or
peritonitis) and more important to empirically initiate an
appropriate antibiotic regimen when the diagnosis is sus-
pected.
Thereisawidevariationinthesymptoms,someofwhich
fail to imply a pelvic etiology, associated with acute PID
(Table 1). They may range from subtle ormild tosevere. This
requires the clinician to maintain a high index of suspicion
for the diagnosis of PID. Alternatively, the signs of PID are
limited to an inﬂammatory exudate from the lower genital
tract and pelvic organ tenderness. The value of recognizing
the symptoms associated with acute PID is based on their
ability to trigger the clinician’s evaluation of the pelvis. If
pelvic examination fails to reveal evidence of inﬂammation
(if there is no leukorrhea), then the diagnosis of PID is
much less likely and antibiotic treatment can be withheld
whiletheremainingdiagnosticworkupdeﬁnesthediagnosis.
However, evidence of lower genital tract inﬂammation and
any pelvic organ tenderness suggests the advisability of
initiating antimicrobial therapy for a diagnosis of PID.
Laparoscopycanconﬁrmthepresenceofacutesalpingitis
in a patient with a clinical diagnosis of PID. However,
laparoscopy cannot be used to dictate which patients are
candidatesforantimicrobialtherapyaswomenwithoutacute
salpingitis still require antimicrobial therapy for a clinical
diagnosis of endometritis without salpingitis. Therefore,
despite laparoscopy being the gold standard for the diagnosis
of acute salpingitis, its routine use is neither feasible nor
recommended.
The clinical diagnosis of PID is imprecise. Most studies
conﬁrm the positive predictive value (PPV) of a clinical
diagnosis of PID for salpingitis of 65% when conﬁrmed
by laparoscopy. No single historical, physical, or laboratory
ﬁnding is reliably diagnostic for acute PID. We are therefore
left with the challenge of diagnosing PID in such a way as to
minimize its associated sequelae while at the same time not
overtreatingallwomenwithpelvicpainorothergenitaltract
symptoms with antimicrobials.2 Infectious Diseases in Obstetrics and Gynecology
Table 1: Symptoms in women with clinically suspected pelvic
inﬂammatory disease.
Abdominal pain
Abnormal discharge
Intermenstrual bleeding
Postcoital bleeding
Fever
Urinary frequency
Low back pain
Nausea/vomiting
Data from [5].
Table 2: Signs and tests to increase the speciﬁcity of a diagnosis of
salpingitis.
An additional sign and abnormal laboratory tests increase the
speciﬁcity of the diagnosis of PID:
(i) Oral temperature >101F (>38.3◦C)
(ii) Elevated C-reactive protein (CRP)
(iii) Laboratory documentation of cervical Neisseria
gonorrhoeae or Chlamydia trachomatis.
The most speciﬁc criteria for diagnosis of PID include:
(i) Endometrial biopsy with histologic evidence of endometritis
(ii) Transvaginal sonography or MRI showing thickened,
ﬂuid-ﬁlled tubes with or without free pelvic or tuboovarian
complex or dopplers studies suggesting pelvic infection
(tubal hyperemia)
(iii) Laparoscopic abnormalities consistent with PID
Data from [2].
2. Challenges
(1) Determine which women presenting with genital
tract symptoms are candidates for antibiotic therapy
for a diagnosis of acute PID.
(2) Determine which women with acute PID actually
have acute salpingitis since these women are at the
highest risk for the reproductive sequelae associated
with this disease.
3. Composite ClinicalCriteria
The diagnosis of PID should be considered in all sexually
active women with or without lower abdominal pain and
symptoms noted in Table 1. An assessment of risk for
sexually transmitted infection (STI) enhances the speciﬁcity
of these presenting symptoms. However, women without
such risk factors should still have the diagnosis considered
given that many will not be accurate in believing that they
reside in a mutually monogamous sexual relationship [1].
Abdominal tenderness may not be present in many women
with PID, particularly if peritonitis is not present or the
patient has endometritis without salpingitis. A bimanual
pelvic examination may reveal pelvic organ tenderness,
uterine tenderness in the case of endometritis, and adnexal
tenderness in the case of salpingitis. Cervical motion ten-
derness is another common ﬁnding in women with PID.
The Centers for Disease Control and Prevention (CDC) [2]
recommend empiric treatment for PID in sexually active
young women (25 years old or younger) and other women
at risk of STI (multiple sex partners or history of STI) if they
are experiencing pelvic or lower abdominal pain, if no cause
for the illness other than PID can be identiﬁed, and if one
or more of the following is appreciated on bimanual pelvic
examination:cervicalmotiontenderness,uterinetenderness,
or adnexal tenderness. The limitation of this approach is
that it fails to discriminate between the diﬀerential diagnoses
o fa c u t ep e l v i cp a i ni nr e p r o d u c t i v e - a g e dw o m e n .F o rt h i s
reason, the lower genital tract needs to be assessed for signs
of inﬂammation. The cervical canal should be examined
for the presence of yellow or green mucopus and friability.
Microscopy of the vaginal secretions should be performed
looking for leukorrhea (more than 1 leukocyte per epithelial
cell). Evaluation for bacterial vaginosis (vaginal pH, clue
cells, and whiﬀ test) and trichomonas vaginitis is in order
[3–6]. Finally, nucleic acid ampliﬁcation testing (NAAT) for
Neisseria gonorrhoeae and Chlamydia trachomatis should be
performed. If the cervix is normal and no white blood cells
are noted during microscopy of the vaginal secretions, an
alternativediagnosis should beinvestigated sincethisreliably
excludes (negative predictive value 94.5%) upper genital
tract infection [7]. Because the sensitivity of microscopy to
detect Trichomonas vaginalis is relatively low (approximately
50%), symptomatic women with cervicitis and negative
microscopy for trichomonads should receive further testing
(i.e., culture or polymerase chain reaction method). Stan-
dardized diagnostic tests for Mycoplasma genitalium are not
routinely performed. Empiric antibiotic treatment should be
initiated in sexually active young women, especially those at
risk for sexually transmitted infections (STIs), with pelvic
or lower abdominal pain, if no other causes other than PID
can be identiﬁed and if the following minimum criteria are
present on pelvic examination:
(i) lower genital tract inﬂammation (cervicitis and/or
leukorrhea (>1 leukocyte per epithelial cell on
microscopy of the vaginal secretions)),
(ii) any pelvic organ tenderness (e.g., cervical motion
tenderness, uterine tenderness, or adnexal tender-
ness).
The above approach is suﬃcient to assure that women with
PID will be treated appropriately with antibiotics. At least
a third of these women will not have acute salpingitis, but
neverthelessarecandidatesforantibiotictherapy.Giventhat
antibiotic regimens are identical for the treatment of women
with acute salpingitis regardless of degree of severity, there is
no utility in conﬁrming the diagnosis laparoscopically.
If women with the clinical diagnosis of PID were to
undergo routine laparoscopy, visual evidence of acute tubal
inﬂammation (erythema, edema, and purulent exudate)
would be conﬁrmed approximately 65% of the time [8,
9]. Therefore, the clinical diagnosis of PID may represent
women with visually conﬁrmed acute salpingitis. However,Infectious Diseases in Obstetrics and Gynecology 3
the clinical diagnosis of PID may also represent women
with cervicitis and endometritis without salpingitis or with
cervicitis alone [10, 11]. C. trachomatis, N. gonorrhoeae,
bacterial vaginosis, and trichomonas vaginitis are associated
with histologic evidence of endometritis in women without
the clinical manifestations of PID [10]. The symptoms and
signs of PID are essentially indistinguishable among women
with acute salpingitis, those with endometritis without acute
salpingitis, and those with cervicitis but neither endometritis
nor salpingitis [11–13].
Other ancillary tests (Table 2) that can be useful in
diagnosing PID include a complete blood count, erythrocyte
sedimentation rate (ESR), or C-reactive protein (CRP).
These tests are recommended for patients with clinically
severe PID. Imaging studies are most helpful when ruling
out competing diﬀerential diagnoses such as the use of
pelvicultrasonographytoruleoutsymptomaticovariancysts
and computed tomography to rule out appendicitis. Pelvic
ultrasonography has limited sensitivity for the diagnosis of
PID, but the speciﬁc ﬁnding of thickened ﬂuid-ﬁlled tubes
by ultrasonography supports the diagnosis of upper genital
tract inﬂammation [14]. Pelvic ultrasonography should be
ordered in patients requiring hospitalization or those with a
pelvic mass.
4.LaboratoryTests
White blood cell (WBC) counts are beneﬁcial when abnor-
mal. However, only 60% of patients with PID present
with elevated serum WBC count [15]. ESR, a nonspeciﬁc
inﬂammatory marker has been found to be elevated in PID
but an elevated ESR (>15mm/h) is only present in approx-
imately 75% of women with acute PID and, as a non-
speciﬁcmakerofinﬂammation,canbefoundinotherdisease
states. CRP, another inﬂammatory marker, has been studied
in acute PID. In a series that involved 152 patients, a CRP
>10mg/dL had a good sensitivity (93%) and speciﬁcity
(83%) in the diagnosis of PID [16]. Furthermore, CRP
levels decrease to normal sooner than ESR following eﬀective
antibiotictherapyandmaybebeneﬁcialasamonitoringtool.
There might be a role for CA-125 in PID diagnosis. Duk
et al. from The Netherlands looked at the relationship of CA-
125 in 50 patients with a provisional diagnosis of PID and
concluded that the ﬁnding of an elevated serum CA-125 level
conﬁrms the diagnosis of peritoneal involvement in patients
with a clinical diagnosis of PID [17]. They measured CA-125
concentrations in serum before laparoscopy and during
hospitalization, using an enzyme immunoassay and found
that CA-125 concentration before laparoscopy correlated
with the extent of inﬂammatory peritoneal involvement and
the predictive value of an elevated serum CA-125 level to
indicate the presence of salpingitis (grades 1–3) was 97%.
However, the predictive value of a normal CA-125 level
indicating normal observations at laparoscopy (grade 0) was
only 47%. Similarly, Mozas and coworkers [18] in Spain
looked at the eﬃciency of diﬀerent tumor markers (CA-125,
carcinoembryonic antigen, CA-15.3, CA-19.9) and insulin-
like growth factor I (IGF-I) measurements as a screening
procedure for acute PID, and found no diﬀerences in the
levels of CA-15.3, CA-19.9, carcinoembryonic antigen and
IGF-I between three groups studied. However, the serum
levels of CA-125 were signiﬁcantly higher in patients who
had PID and they concluded that measurement of serum
CA-125 concentrations is recommended as a useful test for
acute PID in patients undergoing laparoscopy for pelvic
pain. Paavonen and coworkers in Finland measured serum
levels of CA-125 in 31 patients with conﬁrmed PID and
foundacorrelationbetweenCA-125levelsandtheseverityof
adnexal inﬂammation as deﬁned by laparoscopy. There was
no association between isolation of speciﬁc microorganisms
from the upper genital tract and elevated CA-125, and in
most of the women in this study, serum levels of CA-
125 decreased during treatment [19]. Finally, Moore and
Soper [20] also reported a relationship between CA-125
and laparoscopically conﬁrmed acute salpingitis and further
noted that the degree of elevation of CA-125 levels correlated
with severity of tubal inﬂammation.
5.EndometrialBiopsy
Endometrial biopsy has been studied extensively in the diag-
nosis of PID. It is less invasive compared with laparoscopy.
The presence of neutrophils and plasma cells in the endo-
metrium is indicative of endometritis and may be used to
diagnose PID [21].
Kiviat and coworkers [22] looked at endometrial histo-
pathology in 69 patients with clinically suspected acute PID
and reported that 54% of the patients had both upper
genital tract infection (UGTI) and laparoscopically con-
ﬁrmed salpingitis. They reported UGTI without salpingitis
in 1%, while salpingitis without UGTI was reported in 16%.
The study found that the simultaneous presence of ﬁve
or more neutrophils per ×400 ﬁeld in endometrial surface
epithelium, together with one or more plasma cells per ×120
ﬁeld in endometrial stroma were the best predictor of upper
genital tract infection plus salpingitis. This combination had
a sensitivity of 92% and a speciﬁcity of 87% for predicting
the diagnosis of both UGTI and laparoscopically conﬁrmed
acute salpingitis. Additionally, 90% of all UGTIs identiﬁed
in this study were attributable to C. trachomatis or N.
gonorrhoeae, and 92% of the women diagnosed with UGTI
and salpingitis had either chlamydia or gonorrhea infection.
6.ImagingStudies
Ultrasonography is the imaging method of choice, followed
closely by Magnetic Resonance Imaging (MRI). Computed
tomography (CT) is reserved for evaluation of the extent of
PID within the abdomen and interventional management.
Ultrasonography is noninvasive, widely available, and a good
diagnostic tool to have in a physician’s armamentarium
for PID diagnosis. The typical ultrasound ﬁndings in acute
PID have been described by Timor-Tritsch and Rottem
[14], and the addition of Power Doppler to transvaginal
ultrasonography has been found to increase its sensitive in
diagnosis of PID. Transvaginal ultrasonography is preferred
to transabdominal approach and also helpful in guiding nee-
dles to drain abscesses. MRI is expensive but more sensitive.4 Infectious Diseases in Obstetrics and Gynecology
Tukeva et al. [23] compared transvaginal ultrasonography,
MRI, and laparoscopy in 30 in-patients hospitalized in
Finland with clinically suspected PID and reported that MRI
diagnoses were 95% correct in 21 women with laparoscopi-
cally acute salpingitis compared with transvaginal sonogram
that was 81% accurate. The sensitivity of MRI in the
diagnosis of PID was found to be 95%, with a speciﬁcity of
89%, and overall accuracy was 93%. For transvaginal US, the
corresponding value was 81%, 78%, and 80%, respectively.
MRI is more accurate than transvaginal US and provides
information about the diﬀerential diagnosis of PID, and as
such its use may also reduce the need for diagnostic lap-
aroscopy.
Although the literature is replete with reports regarding
the sonographic ﬁndings of PID, little was published about
CT images until the last decade [24]. CT ﬁndings in early
PID include obscuration of the normal pelvic ﬂoor fascial
planes, thickening of the uterosacral ligaments, cervicitis,
oophoritis, salpingitis, and accumulation of simple ﬂuid in
theendometrialcanal,fallopiantubes,andpelvis.Thesimple
ﬂuid may become complex as the disease progresses and
eventually become a frank tuboovarian or pelvic abscess.
Reactive inﬂammation can manifest as small or large bowel
ileus or obstruction, hydronephrosis or hydroureter, and
right upper quadrant inﬂammation (Fitz-Hugh-Curtis syn-
drome).OnedrawbackofCTimageshoweveristheexposure
to ionizing radiation, which can be problematic in young
women.
If imaging is considered, we would ﬁrst recommend
transvaginal ultrasound, and if classic ﬁndings of PID are
noted on ultrasound [14], no further imaging is required.
If additional characterization is warranted, then we recom-
mend MRI over CT because its overall accuracy is greater
than 93% and does not carry the additional risk of ionizing
radiation. If tuboovarian abscess (TOA) is suspected, we
recommend an initial transvaginal ultrasound because this is
the most cost eﬀective imaging to allow percutaneous drain
placement. However, many interventional radiologists will
prefer CT to guide drain placement.
7.Laparoscopy
Laparoscopy has been shown to add considerable accuracy
to the clinical methods of diagnosing acute salpingitis [9].
The procedure does not aggravate the inﬂammatory process.
Jacobson and Westr¨ omlookedat905casesoveraneight-year
period (1960–1967) and set the standard for laparoscopic
diagnosis. The minimum laparoscopic criteria for visual
diagnosisofacutesalpingitisinclude:pronouncedhyperemia
of the tubal surface, edema of the tubal wall, and, thirdly, a
sticky exudate on the tubal surface and from the ﬁmbriated
ends when patent. In their study, they hardly encountered
diﬃculties diﬀerentiating mild pathologic changes and nor-
mal conditions, but one major drawback that can be envis-
aged is the patient with endometritis who has no salpingitis.
In 814 cases in their series with suspected acute PID, 532
(65%) had laparoscopically conﬁrmed acute salpingitis, 12%
had other pathologic conditions, and 23% had no pathologic
conditions changes. We suspect that a signiﬁcant proportion
of women in the latter category had endometritis without
salpingitis.
In another study comparing clinical and laboratory
ﬁndingswithlaparoscopicﬁndingsofacutePID,Eschenbach
and coworkers [25] reported that the severity of clinical and
laboratory manifestations (other than adnexal mass) was
not associated positively with tubal occlusion and that the
severity of some ﬁndings was actually associated negatively
with the severity of tubal damage.
Although laparoscopy is referred to as the “gold stan-
dard” for the diagnosis of PID, review of the literature
regarding its accuracy has been mixed. Accuracy of a clinical
diagnosis when compared with diagnostic laparoscopy in
the diagnosis of PID has been reported in various studies.
Morcos et al. [26] in a study of 176 women with clinically
diagnosed PID established laparoscopically conﬁrmed PID
in 76.1% of the cohort. Similarly, Cohen et al. [21]i na
prospective case-control study investigated the etiology of
acutesalpingitisinacohortofKenyanwomenandconﬁrmed
salpingitis laparoscopically in 142 (90%) of the 158 women
with a clinical diagnosis of acute PID. Conversely, Peipert et
al. [27] found the sensitivities of both the accepted clinical
criteria and the triad of laparoscopy visualization of edema,
erythema and purulent exudates to be low. In that study, the
sensitivities of the CDC’s minimal clinical criteria for PID
and the laparoscopic triad of edema, erythema, and purulent
exudates were 65% and 60%, respectively. Sellors et al. [28]
also found laparoscopy to be 50% and 80% sensitive and
speciﬁc, respectively. In this study, additional evidence from
endometrial and ﬁmbrial biopsy increased the prevalence
of conﬁrmed PID from 30% in visual diagnosis alone to
46% when endometrial and ﬁmbrial minibiopsy evidence
was included.
Women with a recurrent diagnosis of PID and per-
sistently negative NAATs and who are classiﬁed as “lower
risk” epidemiologically should have laparoscopy to consider
alternative diagnoses such as endometriosis.
8. Conclusion
Diagnostic laparoscopy with concomitant endometrial bi-
opsy (subsequently examined histologically) in women with
cervicitis will accurately deﬁne the continuum of inﬂam-
mation associated with a clinical diagnosis of PID. This
approach will allow the clinician/investigator to deﬁne as
to whether the patient/subject has cervicitis/endometritis/
acute salpingitis, cervicitis/endometritis, or cervicitis alone.
This comprehensive approach is neither practical nor cost
eﬀective for those not in a research setting.
A purely clinical approach using the ﬁndings of lower
genital tract inﬂammation (leukorrhea) associated with
pelvic organ tenderness will identify the vast majority of
women with PID, and all are candidates for antibiotic
therapy(Figure 1).Werecommendthisapproachasthemost
practical and cost eﬀective.
Finally, additional testing and imaging is important in
two scenarios ﬁrst, in diﬀerentiating alternative diagnoses
such as ovarian cysts and appendicitis. Second, in the more
seriously ill patient who needs additional evaluation to assessInfectious Diseases in Obstetrics and Gynecology 5
No leukorrhea
or cervicitis
Mild PID Severe PID
Start oral/out
patient antibiotic
therapy
Tests for
GC, CT, TV,
Mg, BV
Proceed to rule
out alternative
diagnosis
Symptoms suggestive of PID
PID: pelvic inﬂammatory disease
LGT: lower genital tract
GC: Neisseria gonorrhoeoa
CT: Chlamydia trachomatis
TV: Trichomonas vaginalis
Mg: Mycoplasma genitalium
BV: bacterial vaginosis
Evaluate LGT for
inﬂammation
+
Bimanual pelvic exam
Start
(i) IV antibiotics
(ii) Hospitalization
(iii) Ancillary tests
(iv) Imaging studies
Figure 1: Flow chart Showing Clinical Diagnosis of PID.
the degree of sepsis and to consider the presence of a
tuboovarian abscess. Women with severe PID are candidates
for hospital admission and parenteral antibiotic therapy.
References
[ 1 ]A .M .J o h n s o n ,J .W a d s w o r t h ,K .W e l l i n g s ,a n dJ .F i e l d ,Sex-
ual Attitudes and Lifestyles, Blackwell Scientiﬁc Publications,
Oxford, UK, 1994.
[2] Centers for Disease Control and Prevention, “Sexually trans-
mitteddiseasestreatment guidelines,”MorbidityandMortality
Weekly Report, vol. 59, no. RR-12, 2010.
[ 3 ]D .E .S o p e r ,N .J .B r o c k w e l l ,H .P .D a l t o n ,a n dD .J o h n s o n ,
“Observations concerning the microbial etiology of acute
salpingitis,”AmericanJournalofObstetricsandGynecology,vol.
170, no. 4, pp. 1008–1017, 1994.
[4] R.L.Sweet,“Roleofbacterialvaginosisinpelvicinﬂammatory
disease,” Clinical Infectious Diseases, vol. 20, no. 2, pp. S271–
S275, 1995.
[5] D. A. Eschenbach, T. M. Buchanan, H. M. Pollock et al.,
“Polymicrobial etiology of acute pelvic inﬂammatory disease,”
New England Journal of Medicine, vol. 293, no. 4, pp. 166–171,
1975.
[6] J. Paavonen, C. W. Critchlow, T. DeRouen et al., “Etiology
of cervical inﬂammation,” American Journal of Obstetrics &
Gynecology, vol. 154, pp. 556–564, 1986.
[7] M. H. Yudin, S. L. Hillier, H. C. Wiesenfeld, M. A. Krohn, A.
J. Amortegui, and R. L. Sweet, “Vaginal polymorphonuclear
leukocytes and bacterial vaginosis as markers for histologic
endometritis among women without symptoms of pelvic
inﬂammatory disease,” American Journal of Obstetrics and
Gynecology, vol. 188, no. 2, pp. 318–323, 2003.
[8] I. Simms, F. Warburton, and L. Westr¨ om, “Diagnosis of pelvic
inﬂammatorydisease:timeforarethink,”SexuallyTransmitted
Infections, vol. 79, no. 6, pp. 491–494, 2003.
[9] L. Jacobson and L. Westr¨ om, “Objectivized diagnosis of acute
pelvic inﬂammatory disease,” American Journal of Obstetrics
and Gynecology, vol. 105, no. 7, pp. 1088–1098, 1969.
[10] H. C. Wiesenfeld, S. L. Hillier, M. A. Krohn et al., “Lower gen-
ital tract infection and endometritis: insight into subclinical
pelvic inﬂammatory disease,” Obstetrics and Gynecology, vol.
100, no. 3, pp. 456–463, 2002.
[ 1 1 ] L .O .E c k e r t ,S .E .H a w e s ,P .K .W¨ olner-Hanssen et al., “Endo-
metritis: the clinical-pathologic syndrome,” American Journal
ofObstetricsandGynecology,vol.186,no.4,pp.690–695,2002.
[ 1 2 ]H .C .W i e s e n f e l d ,R .L .S w e e t ,R .B .N e s s ,M .A .K r o h n ,A .
J. Amortegui, and S. L. Hillier, “Comparison of acute and
subclinical pelvic inﬂammatory disease,” Sexually Transmitted
Diseases, vol. 32, no. 7, pp. 400–405, 2005.
[13] P. Wolner Hanssen, P. A. Mardh, L. Svensson, and L. Westrom,
“Laparoscopy in women with chlamydial infection and pelvic
pain: a comparison of patients with and without salpingitis,”
Obstetrics and Gynecology, vol. 61, no. 3, pp. 299–303, 1983.
[14] I. E. Timor-Tritsch and S. Rottem, “Transvaginal ultrasono-
grapic study of the fallopian tube,” Obstetrics and Gynecology,
vol. 70, pp. 424–428, 1987.
[15] D. E. Soper, “Surgical considerations in the diagnosis and
treatment of pelvic inﬂammatory disease,” Surgical Clinics of
North America, vol. 71, no. 5, pp. 947–962, 1991.
[16] M. Hemila, L. Henriksson, and O. Ylikorkala, “Serum CRP in
the diagnosis and treatment of pelvic inﬂammatory disease,”6 Infectious Diseases in Obstetrics and Gynecology
Archives of Gynecology and Obstetrics, vol. 241, no. 3, pp. 177–
182, 1987.
[17] J. M. Duk, F. M. Kauer, G. J. Fleuren, and H. W. A. De Bruijn,
“Serum CA 125 levels in patients with a provisional diagnosis
of pelvic inﬂammatory disease. Clinical and theoretical impli-
cations,” Acta Obstetricia et Gynecologica Scandinavica, vol. 68,
no. 7, pp. 637–641, 1989.
[18] J. Mozas, J. A. Castilla, P. Jimena, T. Gil, M. Acebal, and A.
J. Herruzo, “Serum CA-125 in the diagnosis of acute pelvic
inﬂammatorydisease,”InternationalJournalofGynecologyand
Obstetrics, vol. 44, no. 1, pp. 53–57, 1994.
[19] J. Paavonen, A. Miettinen, P. K. Heinonen et al., “Serum CA
125 in acute pelvic inﬂammatory disease,” British Journal of
Obstetrics and Gynaecology, vol. 96, no. 5, pp. 574–579, 1989.
[20] E. Moore and D. E. Soper, “Clinical utility of CA125 levels
inpredictinglaparoscopicallyconﬁrmedsalpingitisinpatients
with clinically diagnosed pelvic inﬂammatory disease,” Infec-
tious Diseases in Obstetrics and Gynecology,v o l .6 ,n o .4 ,p p .
182–185, 1998.
[ 2 1 ]C .R .C o h e n ,N .R .M u g o ,S .G .A s t e t ee ta l . ,“ D e t e c t i o no f
mycoplasma genitalium in women with laparoscopically diag-
nosed acute salpingitis,” Sexually Transmitted Infections, vol.
81, no. 6, pp. 463–466, 2005.
[22] N. B. Kiviat, P. Wolner-Hanssen, D. A. Eschenbach et al.,
“Endometrial histopathology in patients with culture-proved
upper genital tract infection and laparoscopically diagnosed
acute salpingitis,” American Journal of Surgical Pathology, vol.
14, no. 2, pp. 167–175, 1990.
[23] T. A. Tukeva, H. J. Aronen, P. T. Karjalainen, P. Molander, T.
Paavonen, and J. Paavonen, “MR imaging in pelvic inﬂamma-
torydisease:comparisonwithlaparoscopyandUS,”Radiology,
vol. 210, no. 1, pp. 209–216, 1999.
[24] J. W. Sam, J. E. Jacobs, and B. A. Birnbaum, “Spectrum of
CT ﬁndings in acute pyogenic pelvic inﬂammatory disease,”
Radiographics, vol. 22, no. 6, pp. 1327–1334, 2002.
[25] D.A.Eschenbach,P.W¨ olner-Hanssen,S.E.Hawes,A.Pavletic,
J. Paavonen, and K. K. Holmes, “Acute pelvic inﬂammatory
disease: associations of clinical and laboratory ﬁndings with
laparoscopic ﬁndings,” Obstetrics and Gynecology, vol. 89, no.
2, pp. 184–192, 1997.
[ 2 6 ]R .M o r c o s ,N .F r o s t ,M .H n a t ,A .P e t r u n a k ,a n dG .C a l d i t o ,
“Laparoscopic versus clinical diagnosis of acute pelvic inﬂam-
matory disease,” Journal of Reproductive Medicine, vol. 38, no.
1, pp. 53–56, 1993.
[27] J. F. Peipert, L. A. Boardman, and C. J. Sung, “Performance
of clinical and laparoscopic criteria for the diagnosis of upper
genital tract infection,” Infectious Diseases in Obstetrics and
Gynecology, vol. 5, no. 4, pp. 291–296, 1997.
[28] J. W. Sellors, J. Mahony, C. Goldsmith et al., “The accuracy
of clinical ﬁndings and laparoscopy in pelvic inﬂammatory
disease,” American Journal of Obstetrics and Gynecology, vol.
164, no. 1 I, pp. 113–120, 1991.